Applied DNA Sciences, Inc. Cash Flow-to-Debt Ratio
Applied DNA Sciences, Inc. cash flow-to-debt ratio. Applied DNA Sciences, Inc. (BNBX) has a Cash Flow-to-Debt Ratio of -1.36x as of March 2026, meaning its operating cash flow of $-2.05 Million could theoretically repay -1% of its total liabilities ($1.50 Million) in one year. Check BNBX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Applied DNA Sciences, Inc. (2021–2025)
Cash flow-to-debt ratio of Applied DNA Sciences, Inc. from 2021 to 2025. Historical debt coverage capacity for Applied DNA Sciences, Inc. across 5 annual periods. Also explore net asset momentum of Applied DNA Sciences, Inc. to track the company's year-over-year net asset growth rate.
Applied DNA Sciences, Inc. Cash Flow-to-Debt Ratio by Year (2021–2025)
Applied DNA Sciences, Inc. cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Applied DNA Sciences, Inc.. For the full cash flow conversion analysis, see Applied DNA Sciences, Inc. cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.02x | $-12.52 Million | $2.50 Million | ▼ -39.8% |
| 2024 | -3.59x | $-13.71 Million | $3.82 Million | ▼ -406.7% |
| 2023 | -0.71x | $-6.22 Million | $8.78 Million | ▲ +26.2% |
| 2022 | -0.96x | $-8.98 Million | $9.36 Million | ▲ +76.3% |
| 2021 | -4.05x | $-13.39 Million | $3.30 Million | — |